Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival

Por Hofmann, U, Szedlak, M, Rittgen, W, Jung, E G, Schadendorf, D
Publicado em 2002

Complement C3c as a Biomarker in Heart Failure

Por Frey, A., Ertl, G., Angermann, C. E., Hofmann, U., Störk, S., Frantz, S.
Publicado em 2013

Identification of Actinobacillus actinomycetemcomitans in subgingival plaque by PCR.

Por Flemmig, T F, Rüdiger, S, Hofmann, U, Schmidt, H, Plaschke, B, Strätz, A, Klaiber, B, Karch, H
Publicado em 1995

Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia–reperfusion

Por Hofmann, U, Hu, K, Walter, F, Burkard, N, Ertl, G, Bauersachs, J, Ritter, O, Frantz, S, Bonz, A
Publicado em 2010

P01.31 Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death

Por Thiepold, A., Foltyn, M., Urban, H., Voss, M., Hofmann, U., Dröse, S., Harter, P. N., Mittelbronn, M., Steinbach, J. P., Ronellenfitsch, M. W.
Publicado no Neuro Oncol (2017)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

Por Hofmann, U B, Westphal, J R, Waas, E T, Zendman, A J W, Cornelissen, I M H A, Ruiter, D J, Muijen, G N P van
Publicado em 1999

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality

Por Dobson, R, Burgess, M I, Valle, J W, Pritchard, D M, Vora, J, Wong, C, Chadwick, C, Keevi, B, Adaway, J, Hofmann, U, Poston, G J, Cuthbertson, D J
Publicado no Br J Cancer (2014)